Human colon stem cells have been identified and grown in a lab plate for the first time. This achievement, made by researchers in the Colorectal Cancer Lab at the Institute for Research in Biomedicine (IRB Barcelona) and published in Nature Medicine, is a crucial advance towards regenerative medicine.
Throughout a person’s lifetime, stem cells of the colon regenerate the inner layer of our large intestine on a weekly basis. For decades, scientists had proof of the existence of these cells yet their identity remained elusive. Scientists led by ICREA Professor and researcher at the Institute for Research in Biomedicine (IRB Barcelona) Eduard Batlle discovered the precise location of the stem cells in the human colon and worked out a method that allows them to be isolated and expanded in vitro, effectively propagating them in lab plates. Growing cells outside the body generally requires providing the cells in a lab plate with the right mix of nutrients, growth factors and hormones. But in the same way that each of the more than 200 types of cells in our body differs from the others, so too do optimal growing conditions in the lab. Consequently, achieving human adult stem cell cultures in labs has been a truly “mission impossible” until now. Batlle’s team has also established the conditions for maintaining living human colon stem cells (CoSCs) outside of the human body: “This is the first time that it has been possible to grow single CoSCs in lab plates and to derive human intestinal stem cell lines in defined conditions in a lab setting,” explains IRB Barcelona researcher Peter Jung, first author of the study together with Toshiro Sato, from the University Medical Center Utrecht in The Netherlands.
The group’s findings, published by Batlle’s research group in the prestigious journal Nature Medicine, arrives after more than 10 years of intense research focused on the characterization of the biology of the intestinal stem cells and their connection with cancer. The research has been conducted as part of a close collaboration between Batlle’s team, the group led by Hans Clevers at the Hubrecht Institute and the University Medical Center Utrecht in The Netherlands, and María A. Blasco at the Spanish National Cancer Research Centre in Madrid (Spain). “For years, scientists all over the world have been trying to grow intestinal tissue in lab plates; testing different conditions; using different nutritive media. But because the vast majority of cells in this tissue are in a differentiated state in which they do not proliferate, they survived only for a few days”, explains Jung. “The aim of this study was to find a way to identify and select individual CoSCs and to grow them while maintaining their undifferentiated and proliferative state in lab conditions. Thus, we would be able to model how they grow —in large numbers— and differentiate into normal intestinal epithelial cells in lab plates”, continues Jung. The scientific community now has a defined ‘recipe’ for isolating CoSCs and deriving stable CoSCs lines, which have the capacity to grow undifferentiated for months. In fact, “now we can maintain stem cells in a plate up to 5 months or we can artificially induce these cells to differentiate, as they do inside our bodies”.
“This achievement opens up an exciting new area of research with the potential to bring about a huge breakthrough in regenerative medicine”, says Jung. Regenerative medicine — or the idea of repairing the body by developing new tissues and organs as the old ones wear out— involves growing new cells from patients into tissues and organs in a lab. However, the main element for making regenerative medicine a reality – adult stem cells – are just starting to be understood. “Now that guidelines for growing and maintaining colon stem cells in the lab are in place, we have an ideal platform that could help the scientific community to determine the molecular bases of gastrointestinal cell proliferation and differentiation. It is also suspected that alterations in the biology of CoSCs are at origin of several diseases affecting the gastrointestinal tract, such as colorectal cancer or Crohn’s disease, an autoimmune and inflammatory disorder. Our discovery paves the way to start exploring this exciting field,” says Jung.
This story is reprinted from material from IRB Barcelona, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.